Updates and news related to prostate cancer:
The Efficacy and Safety of Relugolix vs Leuprolide
HERO study in men with advanced prostate cancer based on baseline BMI
NeuroSAFE Ups Odds of Nerve-Sparing Prostate Cancer Surgery
Neurovascular bundles are spared if intraoperative pathologic examination of tissue adjacent to the bundles following removal of the prostate shows negative surgical margins.
Lynparza Boosts Prostate Cancer Survival
AstraZeneca and Merck's Lynparza won an FDA go-ahead in prostate cancer this past May.
Merck Calls It Quits on Keytruda-Lynparza Combo in Prostate Cancer
The combination of two powerful drugs with excellent clinical track records isn’t necessarily a guarantee for success.
How Realistic is Radical Prostatectomy Without Prior Biopsy?
German case series suggests it may be feasible
Focal Therapy with MRI-Guided Focused Ultrasound
Is it safe for grade group 2 and 3 prostate cancer?
Novel HIFU Approach Effective As Alternative to Radical Prostate Cancer Treatments
Magnetic resonance (MR)–guided focused ultrasound (MRgFUS) focal therapy has shown promise as alternative to surgery, chemotherapy, and radiation in some men with intermediate-risk prostate cancer, according to findings published in Lancet Oncology.
Enzalutamide Is Active in Treating Low- and Intermediate-Risk Prostate Cancer
The researchers found that compared with AS, enzalutamide significantly reduced the risk of prostate cancer progression.
Incorporating Genomic Testing for Prostate Cancer into Your Practice
Daniel Lin joins Alicia Morgans in highlighting a guideline-directed practical course on how to use genomics in clinical practice.
MRI-Guided HIFU Effective in Intermediate-Risk Prostate Cancer
Quality of life outcomes compared favorably with radical prostatectomy and radiotherapy, researchers said.